Literature DB >> 4171834

Fibrinolytic activity and coronary-artery disease.

R Chakrabarti, E D Hocking, G R Fearnley, R D Mann, T N Attwell, D Jackson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4171834     DOI: 10.1016/s0140-6736(68)91104-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

1.  Achieving Optimal Reperfusion without Adjunctive Antithrombotic Therapy: Novel Thrombolytic Dosing Strategies.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1995       Impact factor: 2.300

2.  Effect of myocardial infarction on components of fibrinolytic system.

Authors:  E Gidron; R Margalit; A Oliven; Y Shalitin
Journal:  Br Heart J       Date:  1977-01

Review 3.  Aspirin and exercise as a prophylaxis for heart disease. Is it safe?

Authors:  R E De Meersman
Journal:  Sports Med       Date:  1990-02       Impact factor: 11.136

4.  [The intraindividual variation of fibrinolytic activity in volunteers (author's transl)].

Authors:  J Harenberg; E Walter; E Weber
Journal:  Klin Wochenschr       Date:  1978-05-01

5.  The use of intra-arterial Urokinase in a case of recurrent arterial occlusion.

Authors:  B J Boucher; E M Connolly; S C Farrow
Journal:  Postgrad Med J       Date:  1973-05       Impact factor: 2.401

6.  Varicose veins, deep vein thrombosis, and haemorrhoids: epidemiology and suggested aetiology.

Authors:  D P Burkitt
Journal:  Br Med J       Date:  1972-06-03

7.  Levels of soluble fibrin monomer complexes in the course of myocardial infarction.

Authors:  A Nowak; B Lipiński; J Drzewiecki
Journal:  Br Heart J       Date:  1972-06

8.  Fibrinolysis in cutaneous vasculitis.

Authors:  W J Cunliffe
Journal:  Proc R Soc Med       Date:  1971-09

9.  The fibrinolytic system.

Authors:  G R Fearnley
Journal:  Proc R Soc Med       Date:  1971-09

Review 10.  Antithrombotic drugs: part II.

Authors:  A S Gallus; J Hirsh
Journal:  Drugs       Date:  1976       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.